GHK-Cu calms inflammation and protects the follicle environment
Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction
Take home message Eli Lilly reported on 21 May 2026 that retatrutide produced an average weight loss of up to 30.3% in its Phase 3 TRIUMPH-1 trial, the largest figure reported so far for a weight-loss injection
This layered approachstarting with appropriate dosing, monitoring thyroid labs closely, and refining therapy based on genetic datamaximizes safety and efficacy for complex cases
Best Practices for Safe Use of Brello Health GLP-1 Telehealth Weight Loss Medical Evaluation Required All Brello Health patients undergo a thorough medical intake and telehealth consultation before being prescribed GLP-1 medications
For marketers, this shows that even highly regulated industries can enter mainstream conversation when timing, context, and audience are aligned